1.39
price down icon0.71%   -0.01
after-market After Hours: 1.39
loading
Erasca Inc stock is traded at $1.39, with a volume of 769.52K. It is down -0.71% in the last 24 hours and down -6.08% over the past month. Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
See More
Previous Close:
$1.40
Open:
$1.37
24h Volume:
769.52K
Relative Volume:
0.49
Market Cap:
$351.25M
Revenue:
-
Net Income/Loss:
$-125.04M
P/E Ratio:
-1.6951
EPS:
-0.82
Net Cash Flow:
$-122.99M
1W Performance:
+19.83%
1M Performance:
-6.08%
6M Performance:
-47.35%
1Y Performance:
-26.06%
1-Day Range:
Value
$1.325
$1.42
1-Week Range:
Value
$1.13
$1.55
52-Week Range:
Value
$1.01
$3.45

Erasca Inc Stock (ERAS) Company Profile

Name
Name
Erasca Inc
Name
Phone
(858) 465-6511
Name
Address
10835 ROAD TO THE CURE, SUITE 140, SAN DIEGO
Name
Employee
129
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
ERAS's Discussions on Twitter

Compare ERAS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ERAS
Erasca Inc
1.39 351.25M 0 -125.04M -122.99M -0.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Erasca Inc Stock (ERAS) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-26-25 Initiated Raymond James Outperform
Nov-18-24 Initiated Jefferies Buy
Mar-11-24 Initiated CapitalOne Overweight
Jan-05-24 Downgrade BofA Securities Buy → Neutral
Oct-11-23 Initiated H.C. Wainwright Buy
Mar-30-23 Initiated Mizuho Buy
Feb-24-23 Initiated Goldman Buy
Feb-03-23 Upgrade Morgan Stanley Equal-Weight → Overweight
View All

Erasca Inc Stock (ERAS) Latest News

pulisher
Apr 25, 2025

Erasca, Inc: Carving A Different Niche In RAS Signaling (NASDAQ:ERAS) - Seeking Alpha

Apr 25, 2025
pulisher
Apr 24, 2025

Check out these key findings about Erasca Inc (ERAS) - Sete News

Apr 24, 2025
pulisher
Apr 24, 2025

Analytical Overview: Erasca Inc (ERAS)’s Ratios Tell a Financial Story - DWinneX

Apr 24, 2025
pulisher
Apr 23, 2025

Erasca Inc (ERAS) may enjoy gains as insiders got busy in the recent days - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

ERAS’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Apr 23, 2025
pulisher
Apr 23, 2025

Geode Capital Management LLC Grows Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 23, 2025
pulisher
Apr 21, 2025

JPMorgan Chase & Co. Lowers Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 21, 2025
pulisher
Apr 16, 2025

Is Erasca Inc. (NASDAQ:ERAS) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Yahoo Finance

Apr 16, 2025
pulisher
Apr 14, 2025

Wellington Management Group LLP Acquires New Stake in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

Vanguard Group Inc. Sells 614,840 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

KLP Kapitalforvaltning AS Makes New $69,000 Investment in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

Erasca, Inc. (NASDAQ:ERAS) Shares Acquired by American Century Companies Inc. - Defense World

Apr 11, 2025
pulisher
Apr 08, 2025

Erasca stock hits 52-week low at $1.02 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

Erasca stock hits 52-week low at $1.02 amid market challenges - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Erasca Slides As Insider Purchases Lose Another US$84k - Yahoo Finance

Apr 08, 2025
pulisher
Apr 08, 2025

Erasca (NASDAQ:ERAS) vs. Merck KGaA (OTCMKTS:MKGAF) Head-To-Head Contrast - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Erasca Inc (NASDAQ: ERAS) Stock Sentiment: What’s Wall Street Saying? - stocksregister.com

Apr 07, 2025
pulisher
Apr 05, 2025

Thrivent Financial for Lutherans Sells 29,263 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 05, 2025
pulisher
Apr 04, 2025

Erasca, Inc. (NASDAQ:ERAS) Receives $4.83 Consensus Price Target from Brokerages - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

Teacher Retirement System of Texas Buys 12,345 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Erasca Insiders Lose Out As Stock Sinks To US$1.21 - simplywall.st

Apr 02, 2025
pulisher
Apr 01, 2025

Erasca stock hits 52-week low at $1.23 amid market challenges - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Erasca stock hits 52-week low at $1.23 amid market challenges By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Mar 30, 2025

Erasca (NASDAQ:ERAS) Coverage Initiated by Analysts at Raymond James - MarketBeat

Mar 30, 2025
pulisher
Mar 30, 2025

Erasca, Inc. (NASDAQ:ERAS) Shares Bought by Swiss National Bank - Defense World

Mar 30, 2025
pulisher
Mar 27, 2025

Erasca (NASDAQ:ERAS) Now Covered by Analysts at Raymond James - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Raymond James sets $5 target for Erasca stock, cites valuation gap By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Raymond James Initiates Coverage of Erasca (ERAS) with Outperform Recommendation - Nasdaq

Mar 26, 2025
pulisher
Mar 26, 2025

This Spotify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Raymond James sets $5 target for Erasca stock, cites valuation gap - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

Raymond James Initiates Erasca at Outperform With $5 Price Target - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Erasca initiated with an Outperform at Raymond James - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Charles Schwab Investment Management Inc. Buys 39,066 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting - The Manila Times

Mar 25, 2025
pulisher
Mar 24, 2025

Bank of New York Mellon Corp Grows Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

What is HC Wainwright’s Estimate for Erasca FY2029 Earnings? - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

The Goldman Sachs Group Has Lowered Expectations for Erasca (NASDAQ:ERAS) Stock Price - Defense World

Mar 23, 2025
pulisher
Mar 23, 2025

Erasca (NASDAQ:ERAS) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results - The Manila Times

Mar 21, 2025
pulisher
Mar 21, 2025

Erasca, Inc. Reports 2024 Financial and Strategic Progress - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

Erasca Inc. (ERAS) reports earnings - Quartz

Mar 20, 2025
pulisher
Mar 20, 2025

ERASCA Earnings Results: $ERAS Reports Quarterly Earnings - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Erasca, Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Erasca's $440M War Chest Powers Two Groundbreaking Cancer Drugs Into 2025 Trials - StockTitan

Mar 20, 2025
pulisher
Mar 19, 2025

Erasca (ERAS) Expected to Announce Earnings on Wednesday - Defense World

Mar 19, 2025
pulisher
Mar 10, 2025

Brokerages Set Erasca, Inc. (NASDAQ:ERAS) Price Target at $5.70 - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Morgan Stanley Reaffirms Overweight Rating for Erasca (NASDAQ:ERAS) - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Rhumbline Advisers Boosts Stock Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Erasca’s Promising Oncology Advances: Buy Rating Backed by Strong Market Potential and Competitive Edge - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Erasca, Inc. (NASDAQ:ERAS) Shares Acquired by New York State Common Retirement Fund - Defense World

Mar 07, 2025

Erasca Inc Stock (ERAS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Cap:     |  Volume (24h):